Impact of Photodynamic Therapy as an Adjunct to Non-surgical Periodontal Treatment on Clinical and Biochemical Parameters Among Patients Having Mild Rheumatoid Arthritis With Periodontitis

Not Applicable

Completed

• Conditions: Rheumatoid Arthritis; Chronic Periodontitis

• Registration Number: NCT05122117
• Lead Sponsor: Zohaib Akram

Brief Summary

Purpose: To evaluate the efficacy of photodynamic therapy (PDT) as an adjunct to non-surgical periodontal therapy on the clinical periodontal and biochemical parameters among patients with rheumatoid arthritis (RA) having periodontitis.

Methods: A total of 50 RA patients with periodontitis were included. The subjects were equally divided into two groups: Group A - scaling and root planning (SRP) + PDT; Group B - SRP only, respectively. Plaque score (PS), bleeding on probing (BOP), pocket depth (PD) and clinical attachment level (CAL) were estimated. The biochemical parameters included the assessment of interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α) and rheumatoid factors (RFs). Multiple comparisons were established by employing the Bonferroni's post-hoc test for both clinical and laboratory biomarker data. The Mann-Whitney test was used to compute the p-value for intergroup comparisons. For intra-group comparisons, the p-value was computed with the help of Wilcoxon signed ranks test.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-04
• Primary Completion: 2020-01-15
• Study Completion: 2020-03-02
• Status Verified: 2021-11
• Study First Submitted: 2021-11-03
• Study First Submitted QC: 2021-11-14
• Last Update Submitted: 2021-11-14
• Study First Posted: 2021-11-16
• Last Update Posted: 2021-11-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Patients aged ≥25 years
• Satisfying the 2010 ACR/EULAR categorization criteria (with active RA with ≥6 joint involvement and under anti-RA medication ≥3 months)
• Patients having >20 teeth diagnosed with generalized (>30% of sites) chronic periodontitis with PD ≥ 4mm and/or CAL ≥ 4mm and vertical bone loss of at least 4 mm on radiography.

Exclusion Criteria

• Patients who had underwent periodontal therapy or antimicrobial therapy in the last 6 months
• Any joint replacement
• Pregnancy/lactating mothers
• Patients having other forms of systemic diseases such as diabetes mellitus, hypertension or acquired immunodeficiency syndrome (AIDS)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Probing depth	12 weeks	Measurement of consecutive millimeter markings of the periodontal pocket depth
Clinical attachment level	12 weeks	Measurement of periodontal pocket depth along with recession

Secondary Outcome Measures

Name	Time	Method
Bleeding on probing	12 weeks	Presence or absence of bleeding indicated as '1' or '0', respectively
Tumor necrosis factor alpha	12 weeks	Assessment from gingival crevicular fluid
Plaque index	12 weeks	Presence or absence of plaque indicated as '1' or '0', respectively
Interleukin-6	12 weeks	Assessment from gingival crevicular fluid

Trial Locations

Locations (1)

King Saud University; 🇸🇦 Riyadh, Saudi Arabia